Transcriptomics

Dataset Information

0

Removing a Double Bond from Ceramides Ameliorates Insulin Resistance and Hepatic Steatosis


ABSTRACT: Ceramides contribute to the lipotoxicity that underlies diabetes, hepatic steatosis, and heart disease. By genetically engineering mice, we deleted the enzyme dihydroceramide desaturase-1 (DES1) which inserts a conserved double bond into the backbone of ceramides and other predominant sphingolipids. Ablation of DES1 from whole animals, or tissue-specific deletion in the liver, and/or adipose tissue resolved hepatic steatosis and insulin resistance in mice caused by leptin deficiency or obesogenic diets. Mechanistic studies revealed new ceramide actions that promoted lipid uptake and storage and impaired glucose utilization, none of which could be recapitulated by (dihydro)ceramides that lacked the critical double bond. These studies suggest that inhibition of DES1 may provide a means of treating hepatic steatosis and cardiometabolic disorders.

ORGANISM(S): Mus musculus

PROVIDER: GSE132056 | GEO | 2020/01/30

REPOSITORIES: GEO

Similar Datasets

| PRJNA545734 | ENA
2022-04-04 | PXD031088 | Pride
2020-07-08 | GSE139015 | GEO
2023-05-13 | GSE150626 | GEO
2023-09-07 | PXD041168 | Pride
2022-08-02 | GSE112372 | GEO
2021-07-26 | GSE179228 | GEO
| PRJNA322835 | ENA
2011-04-29 | E-GEOD-16790 | biostudies-arrayexpress
2019-09-15 | GSE129525 | GEO